Primary pulmonary hypertension is a rare disease. The condition was well known to Paul Wood and the clinical features were meticulously presented by him in 1952, but credit for the first full description is usually given to Dresdale et Accepted for publication 6 January 1986 reviews have been multicentre ones, 25 7 or have been cases collected from published reports.8 The identification of risk factors might provide a greater understanding of pathophysiology and ultimately help in treatment.
The haemodynamic, electrocardiographic, and chest x ray findings accompanying clinical deterioration have been reported,3 5 but the relation of these changes to life expectancy has not. Right heart failure usually occurs with time. Some patients with primary pulmonary hypertension have a patent foramen ovale due to persistently raised right atrial pressure. There is experimental evidence that such a shunt can prevent sudden death. 9 10 We examined the prognostic importance of right heart failure and of the presence of a patent foramen ovale.
The influence of associated disease on outcome is uncertain. Pulmonary hypertension is found in association with various connective tissue 450 known. 23 Oral contraception'3 14and pregnancy' have been linked with progressive pulmonary vascular disease-both to the apparent onset of primary pulmonary hypertension and to development of the Eisenmenger syndrome in ventricular septal defect. Presentation in right heart failure towards the end of pregnancy or post partum is well recognised and generally considered to carry a poor immediate and long term outlook. '5 This was not our experience. Finally, survival from time of presentation or onset of symptoms is variable38 and reports of spontaneous regression have been rare8 16 17 except after ingestion of anorectic drugs.6 Regression may occur more frequently than supposed.
Patients and methods
The records of all 34 patients with a diagnosis of primary pulmonary hypertension attending Hammersmith Hospital between 1961 and 1981 were traced. All of them had been followed until death or had survived for at least five years from the time of presentation to a hospital. Those who had been followed up for less than five years and who were still alive were not included in this series. Pulmonary hypertension is deemed to be idiopathic when all known causes have been excluded. We believe that pulmonary perfusion must be assessed before idiopathic pulmonary hypertension can be diagnosed. In a retrospective series of patients with primary pulmonary hypertension in which lung histology was available, such investigations had not been universally applied, and most of those who were misdiagnosed had thromboembolic hypertension.2 The criteria for diagnosis and the number of tests used were: right ventricular hypertrophy on the electrocardiogram in the absence of known cause (34) ; raised pulmonary artery pressure and normal capillary wedge or left ventricular filling pressure (34) ; pulmonary angiogram consistent with primary pulmonary hypertension (29) ; normal ventilation perfusion lung scan (25) ; consistent lung histology (5); M mode echocardiogram (13) . No patient had taken oral contraceptives before presentation and none had been taking anorectic medication at any stage.
Seven patients had more than one cardiac catheterisation. All had had a ventilation perfusion scan or pulmonary angiogram, and most had had both. Nineteen of 25 perfusion lung scans were normal and six showed only minor perfusion abnormalities. '8 19 Pulmonary angiograms showed no evidence of pulmonary emboli. Lung histology was studied at necropsy. The M mode echocardiogram recordings had features consistent with idiopathic pulmonary hypertension in every case. 20 Rozkovec, Montanes, Oakley Follow up was measured from the time of presentation to hospital and ranged from five to 28 years; follow up at Hammersmith Hospital was eight months to 14 years. Data were compiled from our records and those of the referring physicians. Details of the history, examination, electrocardiogram, and chest x ray within the first six months of hospital attendance were available for every subject. Whenever findings were abnormal during this period they were recorded as being those at presentation. Further clinical details were obtained from the patient when possible. Overt right heart failure was defined as a combination of a raised jugular venous pressure, enlargement of the liver, and peripheral oedema. The resting electrocardiogram was analysed for right atrial strain, frontal axis, and evidence of right ventricular hypertrophy. The criteria for right ventricular hypertrophy were fulfilled if two or more of the following four conditions were met: R wave in V1>0 7mV, S wave in V1 <0-2mV, sum of the amplitudes of the R wave in Vi and larger of the S waves in V5 or V6 > 1-05 mV, and R wave in aVR > 0 5 mV.21 Right axis deviation was defined as a mean frontal QRS axis greater than + 900. Chest x rays were assessed by one observer and a radiologist aware of the likely diagnosis, but without knowledge of individual clinical courses. Analysis was subjective and for right ventricular enlargement was based on the lateral view. For the size of the main pulmonary artery, the posterior anterior projection was used. No patient had radiologically detectable interstitial lung disease.
Further 
451 overload were present to a significantly greater degree in those who died within five years than in those who did not. All these features remained unchanged or progressed in the patients of groups I and II who died. There was little response to diuretics and only one patient was treated with digoxin. All were put on warfarin and none was treated with vasodilators. In contrast, two of the four patients in group III were originally in heart failure; one recovered (case 1) and in another (case 2) there was a long period of stable congestive heart failure. Table 3 shows haemodynamic data at rest. There were no significant differences between the three groups for mean right atrial pressure, right ventricular filling pressure, and peak systolic and mean pulmonary artery pressure, although all these variables were higher in groups I and II than in group III. Left ventricular filling pressure (measured directly in six) was greater and cardiac output lower in those who survived <5 years. Pulmonary arteriolar resistance and systemic vascular resistance were lower in those in whom the disease regressed than in those who died within five years of presentation. There was a direct linear relation between pulmonary arteriolar resistance and systemic resistance (r = 0-66, p <0 0005) for patients in all three groups ( Fig. 1) .
We used Spearman's rank correlation (one tailed) to analyse the initial haemodynamic values for individual patients in relation to survival time from presentation. Cardiac ouput was directly related to survival (p <0 0005). The longer the survival, the lower the pulmonary arteriolar resistance ( < 0 005), systemic vascular resistance (p<0.001), and right ventricular end diastolic pressure (p <0025). Correlations for mean systemic, right atrial, and pulmonary artery pressures were not significant.
Repeat catheterisations were performed in three patients in group II and all four in group III. In the group II patients (Fig. 2) there was evidence of progression with a rise in total pulmonary vascular Heart size and electrocardiographic evidence of right ventricular hypertrophy decreased in the three patients who did well. In two of these (cases 3 and 4) symptoms first appeared during and after pregnancy. Case 4 was given a trial of prenylamine and domiciliary oxygen soon after diagnosis and continued to take prenylamine for one year. PA, mean pulmonary artery pressure (mm Hg); CO, cardiac output (I/min); TPVR, total pulmonary vascular resistance (units). Data on patient I are indexed per m2 because she was first studied as an adolescent. subject of a previous report,'6 deteriorated again after a pregnancy and spontaneous abortion (Fig. 3 Right heart failure at presentation 8 
NS
Right heart failure at some stage 18 10 < 0-005 proven primary pulmonary hypertension. The three patients with connective tissue disease lived for < 5 years after presentation. The outcome was significantly better when pulmonary hypertension first appeared during pregnancy (p < 0 02). All five had symptoms towards the end of pregnancy. None went into right heart failure. Two had had one previous uneventful pregnancy. In one patient (case 1) there had been an improvement until her spontaneous abortion. Although right heart failure at presentation was not predictive of a poor outcome, an episode of documented right heart failure at some stage during follow up was associated with poor prognosis (p < 001). Again, case 1 was an exception.
The presence of a patent foramen ovale improved prognosis (p < 0 05).
Discussion
The diagnosis of primary pulmonary hypertension is reached by exclusion. Five patients in this series did not have pulmonary angiograms. Most perfusion lung scans were normal. In primary pulmonary hypertension minor perfusion defects accompanied by normal ventilation on lung scan are sometimes seen,18 19 without histological evidence of pulmonary emboli" whereas chronic thromboembolic pulmonary hypertension always causes major defects. We made every attempt to include only 454 those patients who fulfilled current criteria for pulmonary hypertension of unknown cause. 8 25 The diagnosis can only be established with certainty by examination of a representative lung biopsy specimen of adequate size 22621 this was achieved in five patients. During the period of this study there were four patients with pulmonary veno-occlusive disease; in two the diagnosis was confirmed by lung biopsy and in all it was subsequently confirmed at necropsy. Six patients had thromboembolic pulmonary hypertension. These 10 patients were excluded from the series.
All but two of the patients were first catheterised when aged > 17 years. Onset in childhood is less common.2 28 The sex distribution, with a predominance of females after the menarche is similar to that reported in other series.23 S The reasons for this are unknown8 and this observation is as true of familial as of non-familial primary pulmonary hypertension.29 The finding that a greater proportion of male patients had late onset disease is supported by a previous study.7 Again, the reason for this is unknown.
Age at presentation to hospital rather than onset of symptoms was taken as our reference point, because onset is inevitably poorly defined in such a slowly progressive condition. There was no relation between age at presentation and mean survival, and this accords with previous work.3 The frequency of symptoms was similar to those already reported. 38 12 Breathlessness is usually the first and almost universal complaint.3 812 No patients in our series gave a history consistent with digital vasospasm but not all can be assumed to have been directly questioned about this. The onset of symptoms occurred slightly earlier in those surviving for >5 years. Survival in adults is regarded as being independent of the age of onset. 23 Outcome was poor when clinical right heart failure was evident at presentation to hospital or developed subsequently. The association of right heart failure with mortality is as true of primary pulmonary hypertension5630 as it is of pulmonary hypertension associated with ingestion of aminorex6 and thromboembolic disease.3' Non-invasive measures of right ventricular load and right ventricular size and mass from the electrocardiogram and x ray were no more useful for predicting outcome than were clinical features in those with right heart failure. The pulmonary artery size was unhelpful and is known not to correlate with pulmonary artery pres- (Table 3 ). The patients of group II were catheterised later in their course than those of group I Rozkovec, Montanes, Oakley (Table 3) and their catheter findings indicated more advanced disease. Nevertheless, pulmonary arteriolar resistance was less in patients surviving >5 years from presentation. Pulmonary arteriolar resistance was inversely related to cardiac output, in keeping with the effects of increased afterload on right ventricular function,33 34 and pulmonary artery pressure was not significantly different in the three groups. This has been the usual finding because most patients are not catheterised before an advanced stage of their disease is reached.8 In the few with less advanced disease, pulmonary artery pressure increased with time (Fig. 2) . Mean right atrial pressure and right ventricular filling pressure, indices of right ventricular preload, were lower in those who improved than in those who died within five years. There was no difference between groups I and II, perhaps because of the diuretics used to treat patients with overt heart failure. Furthermore, haemodynamic measurements are known to be labile in this condition, and presumably reflect spontaneous variation in pulmonary vascular tone and right ventricular function. 35 In the group as a whole, increased right ventricular afterload, a low cardiac output, and raised right ventricular filling pressure were of most significance in predicting a poor outcome. As expected the level of pulmonary artery pressure was unrelated to outcome.
Little attention has been paid to the systemic circulation in this condition. The lower the cardiac output the higher the systemic resistance. No important pathological changes are seen in the resistance vessels of the systemic circulation in primary pulmonary hypertension. Selective vasodilatation of the pulmonary circulation is accompanied by a fall in systemic resistance as cardiac output rises.8 33 It follows that the systemic changes are secondary to those in the lung vascular bed. The compensatory changes in systemic resistance with alteration in cardiac output serve to maintain a constant blood pressure, as in other physiological settings. Not surprisingly, systemic and pulmonary arteriolar resistance were closely and directly related (Fig. 1) .
On average, left ventricular filling pressure was highest in patients in group I and lowest in group III. The greater the restriction in venous return to the left heart, the lower the expected left atrial pressure. The fact that the opposite was seen in this study may reflect the decreased compliance of the left ventricle in chronic pulmonary hypertension,36 or, more likely, the difficulty in obtaining an accurate wedged pressure. Decreased compliance may be secondary to the influence of the hypertrophied right ventricle on left ventricular shape and on the mobility of the ventricular septum.2036 It is unlikely Outcome in primary pulmonary hypertension that there is important systolic dysfunction36 since left ventricular filling pressure is not raised and a rise in cardiac output follows the use of a pulmonary vasodilator without a change in filling pressure. 33 3 All three patients who had repeat catheterisation after deterioration showed the expected rise in pulmonary arteriolar resistance and fall in cardiac OUtpUt.8 38 Pulmonary artery pressure rose only slightly (Fig. 2) . The opposite pattern of haemodynamic changes was seen in the three patients in whom symptoms remitted (Fig. 3) . The improvement appears to have been independent of initial severity and presentation in right heart failure. The prenylamine and oxygen may have influenced disease progression in case 4. Epoprostenol (prostacyclin) was used in one patient (case 1) as part of a separate study.39 This naturally occurring agent can reverse vasoconstriction and prevent platelet deposition and release within the lung bed.4042 One report of long term improvement with continuous epoprostenol infusion,43 does not, however, establish that it is more useful than other pulmonary vasodilators, which can also produce long term benefit.4446 Spontaneous regression of pulmonary hypertension in three of our patients suggests that vasolidators, by lowering pulmonary vascular resistance before lung damage is too advanced and pulmonary reactivity is lost,4748 may reduce pulmonary artery pressure, thereby preventing further deterioration.49 Similarly, regression may have occurred in the patient (case 2) in whom pulmonary artery pressure fell as right heart failure occurred. It is more usual for histological changes to advance as lung blood flow falls since this reduction is normally a consequence of right heart failure as pulmonary resistance continues to rise. Factors linked to survival were sought. The presence of another member of the family with primary pulmonary hypertension did not predict outcome. There were only two such patients, however, and a systematic search of the families of other probands might have showed more. Familial primary pulmonary hypertension is generally considered to be inherited as an autosomal dominant trait with varying penetrance.2 29 Although all three patients with connective tissue disease survived less than five years, the outcome in these patients was not significantly worse. Death from right heart failure secondary to pulmonary hypertension occurred a considerable time after the appearance of the initial symptoms.
Connective tissue disease is closely linked with Raynaud's phenomenon, and both are associated with primary pulmonary hypertension.21112 There are several ways by which these entities are interconnected. Firstly, all are more frequent in females. Secondly, in Raynaud's disease and Raynaud's phenomenon the lungs and the extremities are affected. Cold stimulation can cause a reduction in the size of the pulmonary capillary bed in patients with Raynaud's disease and early Raynaud's phenomenon.52
The likely mechanism of this change is precapillary vasoconstriction,52 and implies a generalised mechanism for progressive vascular damage. In scleroderma there is a histological basis for this in that similar changes develop in both digital and pulmonary arteries.53 It is not known if patients with Raynaud's disease ever develop primary pulmonary hypertension. Lastly, the lupus anticoagulant, which is associated with an increased risk of spontaneous thrombosis,54 is found in some systemic lupus patients with apparently non-embolic pulmonary hypertension. 55 Because all patients received anticoagulants their role in primary pulmonary hypertension could not be assessed. 63 Pregnancy at diagnosis seemed to be a favourable prognostic factor. None of the five patients died during a total of eight pregnancies but three of these took place before the onset of symptoms and there was only one further pregnancy after diagnosis. The reported mortality of pregnancy in women with primary pulmonary hypertension is near 50%15 64 with a subsequent mean survival of less than five years.' 5 Our cases presented in late pregnancy or after delivery, and reflected the increased load put on the right ventricle at this time. One of the five patients had a patent foramen ovale. She presented during pregnancy but miscarried. Radiography in childhood showed that she had had pulmonary hypertension at least from the age of 12 years. A patent foramen ovale, by permitting right ventricular unloading, may have accounted for her survival. 65 The favourable outcome for the pregnant group was in part because of spontaneous improvement in two (cases 3 and 4). Prolonged survival after presentation (Table  5 ) might reflect the onset of symptoms earlier in the disease because of the stress of pregnancy or because of some element of reversibility after pregnancy, if this event had accelerated a vasoconstrictive process.
A patent foramen ovale was associated with longer survival. This is in keeping with the better life expectancy of patients with pulmonary hypertension associated with atrial septal defect than with primary pulmonary hypertension.65 Such a shunt, by operating at times of increased demand, permits adequate left ventricular filling and prevents sudden death. 9 10 In the absence of a shunt, exercise and systemic vasodilatation may be associated with hypotension and syncope. 66 The main mechanism for this appears to be inability of the right ventricle to increase its output, perhaps aided by ischaemia secondary to lowered coronary perfusion and increased resistance to right ventricular subendocardial flow.67 -69 Sudden death frequently occurs in primary pulmonary hypertension and usually in the setting of underlying chronic heart failure.8 Surgical creation of an acute shunt by atrial septostomy in a patient with primary pulmonary hypertension was, however, unsuccessful due to the sudden demand put on the left ventricle in the immediate postoperative period.70
In conclusion, primary pulmonary hypertension is a heterogeneous disease that often has a better outcome than expected. 
